| Jun'18 | Jun'17 | Jun'16 | Jun'15 | |||
|---|---|---|---|---|---|---|
Cash flows from operating activities: | ||||||
Net income (loss) | ||||||
0 | 0 | 0 | 0 | |||
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: | ||||||
Depreciation and amortization | ||||||
0 | 0 | 0 | 0 | |||
Impairment losses | ||||||
- | - | - | 0 | |||
Deferred tax expense (benefit) | ||||||
0 | 0 | 0 | 0 | |||
Share based compensation expense | ||||||
0 | 0 | 0 | 0 | |||
Loss on disposal of fixed assets | ||||||
0 | 0 | - | - | |||
Provision for doubtful debts, net | ||||||
- | - | 0 | 0 | |||
Revaluation of liabilities and interest expense on liabilities to the OCS | ||||||
- | - | 0 | 0 | |||
Changes in operating assets and liabilities: | ||||||
Trade accounts receivable, net | ||||||
0 | 0 | 0 | 0 | |||
Inventories | ||||||
0 | 0 | 0 | 0 | |||
Due (to) from affiliates, net | ||||||
0 | 0 | 0 | 0 | |||
Other current assets | ||||||
0 | 0 | 0 | 0 | |||
Trade accounts payable | ||||||
0 | 0 | 0 | 0 | |||
Other current liabilities | ||||||
0 | 0 | 0 | 0 | |||
Liability in respect of settlement | ||||||
0 | 0 | 0 | - | |||
Loss from litigation | ||||||
- | - | 0 | 0 | |||
Liability for employee severance benefits, net | ||||||
0 | 0 | 0 | 0 | |||
Net cash provided by (used in) operating activities of continued operations | ||||||
0 | 0 | 0 | 0 | |||
Cash provided by (used in) operating activities of discontinued operations | ||||||
0 | 0 | 0 | - | |||
Net cash provided by (used in) operating activities | ||||||
0 | 0 | 0 | - | |||
Cash flows from investing activities: | ||||||
Proceeds from disposal of fixed assets | ||||||
0 | 0 | - | - | |||
Repayment of short-term deposits | ||||||
- | - | 0 | 0 | |||
Purchase of fixed assets | ||||||
0 | 0 | 0 | 0 | |||
Purchase of intangible assets | ||||||
0 | 0 | 0 | 0 | |||
Net cash used in investing activities from continuing operations | ||||||
0 | 0 | 0 | 0 | |||
Cash used in (provided by) investing activities of discontinued operations | ||||||
0 | 0 | 0 | - | |||
Net cash provided by (used in) investing activities | ||||||
0 | 0 | 0 | - | |||
Cash flows from financing activities: | ||||||
Proceeds from exercise of share options and RSUs | ||||||
0 | 0 | 0 | - | |||
Repayment of contingent liability | ||||||
- | - | - | 0 | |||
Payment to OCS | ||||||
- | - | 0 | 0 | |||
Share issuance, net | ||||||
- | - | - | 0 | |||
Proceeds from exercise of share options and RSUs | ||||||
- | - | - | 0 | |||
Dividend payment | ||||||
0 | 0 | - | - | |||
Net cash provided by (used in) financing activities from continuing activities | ||||||
0 | 0 | 0 | 0 | |||
Cash provided by financing activities of discontinued operations | ||||||
- | - | 0 | - | |||
Net cash provided by (used in) financing activities | ||||||
0 | 0 | 0 | - | |||
Effect of change in exchange rate on cash and cash equivalents | ||||||
0 | 0 | 0 | 0 | |||
Net increase (decrease) in cash and cash equivalents | ||||||
0 | 0 | 0 | 0 | |||